Yoshifumi Baba,Yoshihiro Hara,Tasuku Toihata,Keisuke Kosumi,Masaaki Iwatsuki,Shiro Iwagami,Yuji Miyamoto,Naoya Yoshida,Yoshihiro Komohara,Hideo Baba

Abstract:We previously demonstrated the relationship of human microbiome Fusobacterium nucleatum with unfavorable clinical outcomes and inferior chemotherapeutic responses in esophageal cancer. Global DNA methylation is associated with the occurrence and development of various cancers. In our previous study, LINE-1 hypomethylation (i.e., global DNA hypomethylation) was associated with a poor prognosis in esophageal cancer. As the gut microbiota may play crucial roles in the DNA methylation of host cells, we hypothesized that F. nucleatum might influence LINE-1 methylation levels in esophageal cancer.

Relationship between gut microbiome Fusobacterium nucleatum and LINE-1 methylation level in esophageal cancer